CALLOS ANDREW (Chief Commercial Officer) sold 20.4% of their position (15K shares) of CYTOKINETICS INC on the open market
Open‑market sale worth $1.11M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/1/2026ACC: 0001061983-26-000065
Officer· Chief Commercial Officer
Since Mar 2021
-15K
Net shares
Net seller
$1.11M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
15K acquired · 30K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+15K
Price / share
$23.26
Trade value
$348.90K
% of position
25.6%
6/1/2026
58.55K→73.56K
Common Stock
Direct
Shares
−15K
Price / share
$74.08
Trade value
$1.11M
% of position
20.4%
6/1/2026
73.56K→58.55K
Total
Net shares
+0.00
Net value
-$762.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2026 | M · Option Exercise | +15K | $23.26 | $348.90K | 25.6% | 58.55K | 73.56K |
| Common Stock Direct | 6/1/2026 | S · Sale | −15K | $74.08 | $1.11M | 20.4% | 73.56K | 58.55K |
| Total | +0.00 | -$762.30K | ||||||
Derivative Transactions1
Non-Qualified Stock Option (Right to Buy)
Direct
Converts to
Common Stock
15K shares
Shares
−15K
Strike price
23.26
Held after
39K
Exercisable
—
6/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (Right to Buy) Direct | Common Stock15K shares | 6/1/2026 | M · Option Exercise | −15K | 23.26 | — | 39K |